MergerLinks Header Logo

Submit Deal

Submit Deal

Announced

Completed

Arcadia Investment Partners-backed Cristae Therapeutics completed the acquisition of a novel bile-acid therapeutics business from Advent International for $25m.

Synopsis

Arcadia Investment Partners-backed Cristae Therapeutics, a UK-based, privately held company, completed the acquisition of a novel bile-acid therapeutics business from Advent International, a private equity firm, for $25m.

Principals

Advent International (novel Bile-acid Therapeutics Business)

target

Advent International (novel Bile-acid Therapeutics Business)

Cristae Therapeutics

bidder

Cristae Therapeutics

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Arcadia Investment Partners-backed Cristae Therapeutics completed the acquisition of a novel bile-acid therapeutics business from Advent International for $25m.